Company Overview of Neurop, Inc.
Neurop, Inc. is a biopharmaceutical company that develops treatments for central nervous system disorders. Its research targets various subunits of neuronal N-methyl-D-aspartate receptors and their therapeutic benefit to treat various central nervous system disorders, including major depression, neuropathic pain, ischemia (stroke), schizophrenia, Alzheimer’s, and Parkinson’s diseases. The company was founded in 2002 and is based in Atlanta, Georgia.
58 Edgewood Avenue, NE
Atlanta, GA 30303
Founded in 2002
Key Executives for Neurop, Inc.
Neurop, Inc. Key Developments
Similar Private Companies By Industry
|Angiocrine Bioscience, Inc.||United States|
|Nova BioGenetics Inc.||United States|
|Molecular Insight Pharmaceuticals, Inc.||United States|
|REVOLUTION Medicines, Inc.||United States|
|Akeso Biomedical, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Neurop, Inc., please visit www.neuropinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.